The rationale and design of TransCon Growth Hormone for the treatment of growth hormone deficiency

The fundamental challenge of developing a long-acting growth hormone (LAGH) is to create a more convenient growth hormone (GH) dosing profile while retaining the excellent safety, efficacy and tolerability of daily GH. With GH receptors on virtually all cells, replacement therapy should achieve the...

Descripción completa

Detalles Bibliográficos
Autores principales: Sprogøe, Kennett, Mortensen, Eva, Karpf, David B, Leff, Jonathan A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bioscientifica Ltd 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5655688/
https://www.ncbi.nlm.nih.gov/pubmed/28947559
http://dx.doi.org/10.1530/EC-17-0203

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5655688/
https://www.ncbi.nlm.nih.gov/pubmed/28947559
http://dx.doi.org/10.1530/EC-17-0203

Ejemplares similares